Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 4/20 | 0.44 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.40 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.40 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.40 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.40 |
| ▸ | TOP2A | P11388 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B3 | P37058 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL562208 | 0.92 | ELANE (0.46) | KDM4ECNR2CNR1ALOX15POLM | |
| SCHEMBL562207 | 0.92 | ELANE (0.46) | KDM4ECNR2CNR1ALOX15POLM | |
| SCHEMBL561842 | 0.81 | NR5A1 (0.45) | HTTCNR2CNR1ALOX15 | |
| SCHEMBL11674325 | 0.79 | CNR2 (0.51) | KDM4EHTTCNR2CNR1ALOX15 | |
| SCHEMBL563157 | 0.77 | HTT (0.48) | KDM4EHTTCNR2CNR1ALOX15 | |
| SCHEMBL563127 | 0.77 | HTT (0.48) | KDM4EHTTCNR2CNR1ALOX15 | |
| SCHEMBL562525 | 0.77 | HTT (0.48) | KDM4EHTTCNR2CNR1ALOX15 | |
| SCHEMBL5822064 | 0.75 | KDM4E (0.51) | KDM4EHTTCNR2CNR1ALOX15 | |
| SCHEMBL3946747 | 0.75 | CNR2 (0.67) | HTTCNR2CNR1ALOX15ALDH1A1 | |
| SCHEMBL25350721 | 0.74 | ALOX15 (0.50) | HTTCNR2CNR1ALOX15POLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | claimed |
| EP-2417104-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | Pierre Fabre Dermo-Cosmétique (FR) | 2012-02-15 | — | — | EP | claimed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | claimed |
| WO-2010115945-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-10-14 | — | — | WO | claimed |
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | disclosed |
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | disclosed |
| US-8859819-B2 | Sulphurated derivatives of resorcinol, preparation of same and cosmetic uses thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2014-10-14 | — | — | US | disclosed |
| EP-2417104-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | Pierre Fabre Dermo-Cosmétique (FR) | 2012-02-15 | — | — | EP | disclosed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | disclosed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | disclosed |
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2012-02-09 | — | — | US | disclosed |
| WO-2010115945-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010115945-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2010-10-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120034176-A1 | SULPHURATED DERIVATIVES OF RESORCINOL, PREPARATION OF SAME AND COSMETIC USES THEREOF | CBR3, ACSL3, MSRB3 | KDM4E 4077/4885HTT 2325/4885CNR2 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.